Mitral Valve Insufficiency

• 

  Subject Areas on Research

  • 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. 
  • 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. 
  • 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. 
  • 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. 
  • A Novel Approach to Assess the Three-Dimensional Anatomy of a Mitral Valve Regurgitant Jet Orifice. 
  • A clinical comparison of mitral valve repair versus valve replacement in ischemic mitral regurgitation. 
  • A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement. 
  • A pathoanatomic approach to secondary functional mitral regurgitation: Evaluating the evidence. 
  • Acquired dynamic left ventricular outflow tract obstruction complicating acute anterior myocardial infarction: serial echocardiographic and clinical evaluation. 
  • Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. 
  • Acute myocardial infarction and cardiac arrest due to coronary artery perforation after mitral valve surgery: successful treatment with a covered stent. 
  • Advances in the surgical treatment of heart failure. 
  • Aortic stenosis and mitral regurgitation: not as simple as it looks. 
  • Apex cardiogram in patients with prolapsing mitral valve. 
  • Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. 
  • Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study. 
  • Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation. 
  • Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair. 
  • Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry. 
  • Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures. 
  • Asymmetric versus symmetric tethering patterns in ischemic mitral regurgitation: geometric differences from three-dimensional transesophageal echocardiography. 
  • Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention. 
  • Biplane cineangiographic determinations of left ventricular function: pressure-volume relationships. 
  • CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. 
  • COAPTing Heart Failure Physicians, Interventional Cardiologists, and CardioThoracic Surgeons: A New Opportunity for Patients. 
  • Cardiac manifestations of Q fever infection: case series and a review of the literature. 
  • Cardiac morphology and function in senescent rats: gender-related differences. 
  • Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. 
  • Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients. 
  • Case 4-2007. Aprotinin-induced cardiovascular collapse after a negative test dose in a patient scheduled for repeat mitral valve surgery. 
  • Catastrophic antiphospholipid syndrome after cardiac surgery. 
  • Catheter-Based Management of Heart Failure: Pathophysiology and Contemporary Data. 
  • Choice of agreement indices for assessing and improving measurement reproducibility in a core laboratory setting. 
  • Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 
  • Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. 
  • Clinical application of cine-MRI in the visual assessment of mitral regurgitation compared to echocardiography and cardiac catheterization. 
  • Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. 
  • Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. 
  • Clinical implications of pulmonary hypertension in mitral stenosis. 
  • Clinical problem-solving. Taken out of context. 
  • Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium. 
  • Closed mitral valvotomy for mitral restenosis: experience in 113 consecutive cases. 
  • Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation. 
  • Combined TMR and mitral valve replacement via left thoracotomy. 
  • Commentary: Technology to make the invisible "visible": Novel optical visualization system for off-pump artificial chordae implantation. 
  • Comparison of survival after mitral valve replacement with biologic and mechanical valves in 1139 patients. 
  • Complications related to percutaneous transvenous mitral commissurotomy. 
  • Congenital Double Orifice Mitral Valve Is A Repairable Condition. 
  • Congenital mitral insufficiency secondary to anomalous mitral arcade in an adult. 
  • Congenital pulmonary capillary hemangiomatosis: Report of two cases and review of the literature. 
  • Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. 
  • Correlation of cine MR imaging with two-dimensional pulsed Doppler echocardiography in valvular insufficiency. 
  • Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network. 
  • Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation. 
  • Current management of mitral valve incompetence associated with coronary artery disease. 
  • Current prognosis of ischemic mitral regurgitation. Implications for future management. 
  • Cutting corners. 
  • Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. 
  • Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. 
  • Differences in Two- and Three-Dimensional Assessment of the Mitral Valve by Novices and Experts, Illustrated Using Anterior Mitral Valve Leaflet Length. 
  • Does mitral valve repair offer an advantage over replacement in patients undergoing aortic valve replacement? 
  • Doppler pressure half-time method of assessing mitral valve area: aortic insufficiency does not adversely affect validity. 
  • Dynamic indices of mitral valve function using perioperative three-dimensional transesophageal echocardiography. 
  • Dynamic mitral regurgitation without regional wall motion abnormality. 
  • Dyssynchrony: a different kind of mitral regurgitation. 
  • EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. 
  • Early changes in left ventricular size and function after correction of left ventricular volume overload. 
  • Echocardiography of the mitral valve. 
  • Effect of balloon size and stepwise inflation technique on the acute results of Inoue mitral commissurotomy. Inoue Balloon Catheter Investigators. 
  • Effect of dobutamine stress echocardiography on mitral regurgitation. 
  • Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies. 
  • Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. 
  • Effect of valve deformity on results and mitral regurgitation after Inoue balloon commissurotomy. 
  • Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. 
  • Effects of sample volume location, imaging view, heart rate and age on tricuspid velocimetry in normal subjects. 
  • Effects of standard mitral valve replacement on left ventricular function. 
  • Effects of valve replacement on ventricular mechanics in mitral regurgitation and aortic stenosis. 
  • Etiology and differential diagnosis of acute mitral regurgitation. 
  • Evaluation of renal function before and after percutaneous mitral valve repair. 
  • Experimental mitral regurgitation. Physiological effects of correction on left ventricular dynamics. 
  • Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities. 
  • Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients. 
  • Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies. 
  • Hemolytic anemia following insertion of Ionescu-Shiley mitral valve bioprosthesis. 
  • Immediate hemodynamic effects of acute coronary occlusion and their modification by anesthesia. 
  • Immersion-Induced Mitral Regurgitation: A Novel Risk Factor for Swimming-Induced Pulmonary Edema. 
  • Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty. 
  • Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair. 
  • Impact of early surgery on survival of patients with severe mitral regurgitation. 
  • Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial. 
  • Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. 
  • Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. 
  • Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study. 
  • Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. 
  • Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. 
  • In vitro analysis of jets by Doppler colour flow imaging: the importance of time to maximum jet area. 
  • Incidental moderate mitral regurgitation in patients undergoing coronary artery bypass grafting: update on guidelines and key randomized trials. 
  • Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. 
  • Influence of jet direction on pulmonary vein flow patterns in severe mitral regurgitation. 
  • Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. 
  • Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry's disease. 
  • Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States. 
  • Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. 
  • Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes: Insights From the TVT Registry. 
  • Intermediate Outcomes After Repair of Anomalous Left Coronary Artery From the Pulmonary Artery. 
  • Intraoperative Evaluation of Paravalvular Regurgitation by Transesophageal Echocardiography. 
  • Intraoperative transesophageal Doppler color flow imaging used to guide patient selection and operative treatment of ischemic mitral regurgitation. 
  • Intraprocedural Cardiac Complications of Transcatheter Aortic and Mitral Valve Interventions: "The Eyes Do Not See What the Mind Does Not Know". 
  • Invited Commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation. 
  • Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment. 
  • Ischemic mitral regurgitation. 
  • Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis. 
  • Isolated mitral valve repair in patients with depressed left ventricular function. 
  • Isolated mitral valve surgery risk in 77,836 patients from the Society of Thoracic Surgeons database. 
  • Late Durability of Mitral Repair for Ischemic Versus Nonischemic Functional Mitral Regurgitation. 
  • Left ventricular filling and ventricular diastolic performance after percutaneous balloon mitral valvotomy. 
  • Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. 
  • Letter: Ventricular septal defect and mitral regurgitation secondary to myocardial infarction. 
  • Libman-Sacks endocarditis in pediatric patient with systemic lupus erythematosus. 
  • Long-term outcomes of mitral regurgitation by type and severity. 
  • Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. 
  • Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. 
  • M-mode echocardiographic observations during and after healing of active bacterial endocarditis limited to the mitral valve. 
  • Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. 
  • Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). 
  • Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty. The NHLBI Balloon Valvuloplasty Registry. 
  • Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. 
  • Minimally invasive edge-to-edge mitral repair with or without artificial chordae. 
  • Mitral Intervention with LVAD: Preparing for Recovery. 
  • Mitral Regurgitation After Orthotopic Lung Transplantation: Natural History and Impact on Outcomes. 
  • Mitral Valve Prolapse, Psychoemotional Status, and Quality of Life: Prospective Investigation in the Current Era. 
  • Mitral Valve Surgical Volume and Transcatheter Mitral Valve Repair Outcomes: Impact of a Proposed Volume Requirement on Geographic Access. 
  • Mitral gradients and frequency of recurrence of mitral regurgitation after ring annuloplasty for ischemic mitral regurgitation. 
  • Mitral regurgitation in left ventricular noncompaction cardiomyopathy assessed by cardiac MRI. 
  • Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation. 
  • Mitral regurgitation: focusing on the cause rather than the effect. 
  • Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation. 
  • Mitral valve repair or replacement in elderly people. 
  • Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. 
  • Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. 
  • Multimodal Evaluation of Aortic Regurgitation After Mitral and Tricuspid Valve Repairs. 
  • Myocardial Contractile Mechanics in Ischemic Mitral Regurgitation: Multicenter Data Using Stress Perfusion Cardiovascular Magnetic Resonance. 
  • Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse. 
  • Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. 
  • Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. 
  • One-Year Outcomes After MitraClip for Functional Mitral Regurgitation. 
  • Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States. 
  • Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? 
  • Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. 
  • Outcomes After Transcatheter Mitral Valve Repair in Patients With Renal Disease. 
  • Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. 
  • Partial and transitional atrioventricular septal defect outcomes. 
  • Pathological Remodeling of Mitral Valve Leaflets from Unphysiologic Leaflet Mechanics after Undersized Mitral Annuloplasty to Repair Ischemic Mitral Regurgitation. 
  • Pathological healing response of explanted MitraClip devices. 
  • Patient selection for percutaneous mitral valve repair: insight from early clinical trial applications. 
  • Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. 
  • Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms. 
  • Percutanenous therapies for mitral regurgitation. 
  • Percutaneous edge-to-edge leaflet repair: a solution to the risk-treatment paradox of mitral regurgitation complicated by pulmonary hypertension? 
  • Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. 
  • Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. 
  • Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. 
  • Percutaneous repair or surgery for mitral regurgitation. 
  • Performing Concomitant Tricuspid Valve Repair at the Time of Mitral Valve Operations Is Not Associated With Increased Operative Mortality. 
  • Physician heal thyself. 
  • Physiology of the third heart sound: novel insights from tissue Doppler imaging. 
  • Port-Access Mitral Valve Surgery-An Evolution of Technique. 
  • Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel. 
  • Pre- Versus Post-Procedure Health Care Resource Utilization in Patients Undergoing Commercial Transcatheter Mitral Valve Repair. 
  • Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. 
  • Predictors of inotrope use during separation from cardiopulmonary bypass. 
  • Predictors of mitral valve repair: clinical and surgeon factors. 
  • Pressure and volume changes of the left ventricle in acute pericardial tamponade. 
  • Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease. 
  • Prevalence and clinical associations of mitral and aortic regurgitation in patients with aortic stenosis. 
  • Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). 
  • Prevalence of multivalvular regurgitation in athletes. 
  • Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation. 
  • Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. 
  • Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. 
  • Prosthetic mitral valve replacement: late complications after native valve preservation. 
  • Psycho-emotional manifestations of valvular heart diseases: prospective assessment in mitral regurgitation. 
  • Psychoemotional and quality of life response to mitral operations in patients with mitral regurgitation: a prospective study. 
  • Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair. 
  • Pulmonary dysfunction after lung transplantation: the dilemma of coexisting mitral regurgitation. 
  • Pulmonary hypertension and long-term mortality in aortic and mitral regurgitation. 
  • Pulsed Doppler spectral analysis of bounded fluid jets. 
  • Pure annular dilation as a cause of mitral regurgitation: a clinically distinct entity of female heart disease. 
  • Quality of life after early mitral valve repair using conventional and robotic approaches. 
  • Quantitative assessment of mitral valve coaptation using three-dimensional transesophageal echocardiography. 
  • Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. 
  • Redo mitral surgery without transcatheter options: A case of 7 consecutive mitral operations. 
  • Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. 
  • Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. 
  • Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. 
  • Reply: Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiogenic Shock and Severe Mitral Regurgitation. 
  • Reply: Surgical and transcatheter therapy for secondary mitral regurgitation. 
  • Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis. 
  • Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty". 
  • Response to letter regarding article, "surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience". 
  • Restrictive Mitral Annuloplasty: Patient Selection Is the Key. 
  • Rheumatic heart disease and other valvular disorders in women. 
  • Right Ventricular Function in Left Heart Disease. 
  • Risk factors in coronary artery bypass surgery. 
  • Risk for non-home discharge following surgery for ischemic mitral valve disease. 
  • Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation. 
  • Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation. 
  • Robotic versus port-access mitral repair: A propensity score analysis. 
  • Routine cine-CMR for prosthesis-associated mitral regurgitation: a multicenter comparison to echocardiography. 
  • Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated? 
  • Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure. 
  • Several new considerations in mitral valve repair. 
  • Severe mitral incompetence following balloon mitral valvuloplasty: complete resolution during follow-up. 
  • Severe tricuspid valve regurgitation: a case for laminar flow. 
  • Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. 
  • Sex-Based Differences in Outcomes With Percutaneous Transcatheter Repair of Mitral Regurgitation With the MitraClip System: Transcatheter Valve Therapy Registry From 2011 to 2017. 
  • Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United States. 
  • Strategies to attenuate pathological remodeling in heart failure. 
  • Surgical approaches to mitral regurgitation. 
  • Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. 
  • Surgical revision after percutaneous mitral repair with the MitraClip device. 
  • Surgical treatment of moderate ischemic mitral regurgitation. 
  • Surgical treatment of moderate ischemic mitral regurgitation. 
  • Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. 
  • Survival prognosis and surgical management of ischemic mitral regurgitation. 
  • Sustained results of robotic mitral repair in a lower volume center with extensive minimally invasive mitral repair experience. 
  • Task Force 3: valvular heart disease. 
  • Ten-year experience with mitral valve replacement in the elderly. 
  • The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. 
  • The Hostile Thoracic Aorta: Management Considerations for Severe Aortic Atheroma in a Challenging Case of Coronary Artery Bypass Grafting and Mitral Valve Replacement. 
  • The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations. 
  • The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. 
  • The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • The Risk of Sudden Cardiac Death in Mitral Valve Prolapse: Are All Patients Created Equal? 
  • The Value of Echocardiography in Unexpected Valve Disease in a Patient With Ischemic Cardiomyopathy: Less Is Not Always the Right Answer. 
  • The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2015. 
  • The acute hemodynamic effects of MitraClip therapy. 
  • The application of official policy. Prophylaxis recommendations for patients with mitral valve prolapse. 
  • The hemodynamic simulation of mitral regurgitation in ventricular septal defect after myocardial infarction. 
  • The outcome of mitral repair for degenerative versus ischemic mitral regurgitation using a single complete ring. 
  • The progression of fenfluramine-associated valvular heart disease assessed by echocardiography. 
  • Three-dimensional modeling of the mitral valve for surgical planning in a pediatric patient: A case-based discussion of the technical challenges of segmentation and printing from 3D transthoracic echocardiographic datasets. 
  • Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation. 
  • Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock. 
  • Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry. 
  • Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence. 
  • Transesophageal echocardiographic assessment of reversal of systolic pulmonary venous flow in mitral stenosis. 
  • Transesophageal echocardiography and evaluation of valvular heart disease. 
  • Transseptal Access-Gateway to Transcatheter Mitral Interventions. 
  • Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial. 
  • Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. 
  • Trends in the surgical treatment of ischemic mitral regurgitation: effects of mitral valve repair on hospital mortality. 
  • Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure. 
  • Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. 
  • Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. 
  • Two-dimensional echocardiographic findings in atrial septal defect. 
  • Use of Medicare Claims to Identify Adverse Clinical Outcomes After Mitral Valve Repair. 
  • Using a Regent Aortic Valve in a Small Annulus Mitral Position Is a Viable Option. 
  • Valve-in-Valve Transcatheter Valve Implantation in the Nonaortic Position. 
  • Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Variation in resource utilization and mortality among patients with varying MR type and severity. 
  • Ventricular pacing can induce hemodynamically significant mitral valve regurgitation. 
  • Vigilance in Mitral Regurgitation: Variation and the Way Forward. 
  • Volume-Outcome Association of Mitral Valve Surgery in the United States. 
  • [Giant left atrium combined with mitral valvular disease: morphologic classification and its clinical significance]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology